U.S., Aug. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07148960) titled 'Does Staphylococcus Aureus Bacteremia Early Dual Therapy Improve Outcomes?' on Aug. 22.
Brief Summary: The goal of this open-label, pragmatic, randomized controlled clinical trial is to learn if patients with Staphylococcus aureus bacteremia (SAB) given the intervention of early dual intravenous (IV) antibiotic therapy will decrease duration of bacteremia (< 6 days) and improve outcomes compared to single IV antibiotic therapy.
The main questions this study aims to answer are:
* To decrease SAB duration and improve outcomes by using early dual vs. single agent IV antibiotic therapy
* To accelerate practice transformation of earli...